During the past decade, Southampton General Hospital conducted 169 clinical trials. In the 10-year time frame, 169 clinical trials started and 85 clinical trials were completed, i.e. on average, 50.3% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 53 clinical trials were completed. i.e. 96.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southampton General Hospital" #1 sponsor was "Children's Cancer and Leukaemia Group" with 29 trials, followed by "Hoffmann-La Roche" with 19 trials sponsored, "University College, London" with 18 trials sponsored, "University Hospital Southampton NHS Foundation Trust" with 16 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 16 trials sponsored. Other sponsors include 264 different institutions and companies that sponsored additional 152 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southampton General Hospital" #1 collaborator was "Cancer Research UK" with 30 trials as a collaborator, "AstraZeneca" with 9 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 8 trials as a collaborator, "Celgene" with 5 trials as a collaborator and "Roche Pharma AG" with 5 trials as a collaborator. Other collaborators include 215 different institutions and companies that were collaborators in the rest 187 trials.

According to Clinical.Site data, the most researched conditions in "Southampton General Hospital" are "Cystic Fibrosis" (20 trials), "Brain and Central Nervous System Tumors" (15 trials), "Lymphoma" (15 trials), "Breast Cancer" (11 trials) and "Ovarian Cancer" (11 trials). Many other conditions were trialed in "Southampton General Hospital" in a lesser frequency.

Most popular intervention types in "Southampton General Hospital" are "Drug" (272 trials), "Procedure" (68 trials), "Biological" (58 trials), "Other" (46 trials) and "Radiation" (41 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (51 trials), "radiation therapy" (26 trials), "adjuvant therapy" (24 trials), "carboplatin" (23 trials) and "cyclophosphamide" (22 trials). Other intervention names were less common.

The vast majority of trials in "Southampton General Hospital" are 332 trials for "All" genders, 17 trials for "Male" genders and 16 trials for "Female" genders.

Currently, there are 81 active trials in "Southampton General Hospital". 1 are not yet recruiting, 39 are recruiting, 40 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 179 completed trials in Southampton General Hospital, 1 suspended trials, and 36 terminated clinical trials to date.

Out of the total trials that were conducted in Southampton General Hospital, 39 "Phase 1" clinical trials were conducted, 109 "Phase 2" clinical trials and 163 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 36 trials that are defined as “Not Applicable".

Southampton General Hospital has several departments that took part in Clinical trials: "Southampton General Hospital; Medical Oncology" - 9 trials, "Southampton Children's Hospital" - 6 trials, "University Southampton NHS Foundation Trust; Wessex Neurologica Centre" - 5 trials, "Haemophilia Centre, Southampton General Hospital, Tremona Road" - 3 trials, "Southampton University Hospitals NHS Trust" - 29 trials, "Southampton General Hospital; Respiratory Department" - 3 trials, "University Hospital Southampton NHS Foundation Trust; Southampton Eye Unit" - 3 trials, "Southampton General Hospital; Pharmacy" - 2 trials